These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9000814)

  • 1. Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease.
    Lee ST; Lu CS
    J Formos Med Assoc; 1996 Dec; 95(12):943-5. PubMed ID: 9000814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa-induced dyskinesia and thalamotomy.
    Narabayashi H; Yokochi F; Nakajima Y
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):831-9. PubMed ID: 6381653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of thalamotomy in the treatment of levodopa-induced dyskinesia.
    Page RD
    Acta Neurochir (Wien); 1992; 114(3-4):77-117. PubMed ID: 1580197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
    Ohye C
    Stereotact Funct Neurosurg; 2000; 75(2-3):54-65. PubMed ID: 11740171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
    Page RD; Sambrook MA; Crossman AR
    Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic oromandibular dyskinesia treated by Vo complex microstereotactic thalamotomy.
    Narabayashi H; Yokochi F; Nakajima Y
    Appl Neurophysiol; 1985; 48(1-6):309-14. PubMed ID: 3915654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex.
    Caparros-Lefebvre D; Blond S; Feltin MP; Pollak P; Benabid AL
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):308-14. PubMed ID: 10449551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
    Pourcher E; Bonnet AM; Kefalos J; Dubois B; Agid Y
    Mov Disord; 1989; 4(3):195-201. PubMed ID: 2779590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
    Carpentier AF; Bonnet AM; Vidailhet M; Agid Y
    Neurology; 1996 Jun; 46(6):1548-51. PubMed ID: 8649546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Onset-and end-of-dose dyskinesias induced by L-dopa treatment in a patient with juvenile parkinsonism].
    Katsuki T; Shimizu N; Mizuno Y
    No To Shinkei; 1984 Dec; 36(12):1201-5. PubMed ID: 6529518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of treatment with levodopa on Parkinson's disease.
    Shaw KM; Lees AJ; Stern GM
    Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
    Crossman AR
    Mov Disord; 1990; 5(2):100-8. PubMed ID: 1970120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease.
    Figueiras-Méndez R; Marín-Zarza F; Antonio Molina J; Jiménez-Jiménez FJ; Ortí-Pareja M; Magariños C; López-Pino MA; Martínez V
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):549-50. PubMed ID: 10201440
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
    Papathanou M; van der Laan R; Jenner P; Rose S; McCreary AC
    Mov Disord; 2013 Jul; 28(8):1072-9. PubMed ID: 23125107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of levodopa-induced dyskinesia in Parkinson's disease.
    Caligiuri MP; Peterson S
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):89-98. PubMed ID: 8117413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].
    Taguchi S; Niwa J; Ibi T; Doyu M
    Rinsho Shinkeigaku; 2015; 55(3):182-4. PubMed ID: 25786757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid therapy in Parkinson's disease.
    Gershanik OS; Luquin MR; Scipioni O; Obeso JA
    Mov Disord; 1988; 3(2):133-9. PubMed ID: 3221901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present role of stereotactic thalamotomy for parkinsonism. Retrospective analysis of operative results and thalamic lesions in computed tomograms.
    Miyamoto T; Bekku H; Moriyama E; Tsuchida S
    Appl Neurophysiol; 1985; 48(1-6):294-304. PubMed ID: 3915652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.